Biological Features Imply Potential Use of Autologous Adipose-Derived Stem/Progenitor Cells in Wound Repair and Regeneration for Patients with Lipodystrophy

The study investigated the use of autologous adipose-derived stem/progenitor cells (ADSCs) for regenerative therapy in patients with lipodystrophy, particularly those with HIV-associated lipodystrophy due to HAART. ADSCs were isolated from 3 HIV-infected and 4 uninfected patients. Results showed that ADSCs from HIV-infected patients had similar growth, differentiation capabilities, and oxidative stress levels as those from uninfected patients, indicating their potential for adipose tissue reconstitution. Despite a lower recovery rate from HIV-infected patients, ADSCs retained normal physiological activity, suggesting they could be a viable option for autologous regenerative therapy, offering a less invasive alternative to traditional fat tissue transplantation. However, the study recommended further research due to the limited number of cases examined.